Synthesis and Antitumor Activity of Sorafenib Analogs Containing a Tetrazole Moiety

doi:10.1007/s40242-018-8236-5

Chemical Research in Chinese Universities ›› 2019, Vol. 35 ›› Issue (1): 41-46.doi: 10.1007/s40242-018-8236-5

• Articles • Previous Articles Next Articles

Synthesis and Antitumor Activity of Sorafenib Analogs Containing a Tetrazole Moiety

TIAN Ye¹, YU Simiao¹, CAI Lude¹, GONG Guowei², WU Guodong¹, QI Hongxia³, ZHAO Yanfang¹, QIN Mingze¹

1. Key Laboratory of Structure-based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China;
2. Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, P. R. China;
3. Shengjing Hospital of China Medical University, Shenyang 110016, P. R. China

Received:2018-07-20 Revised:2018-10-25 Online:2019-02-01 Published:2018-11-12
Contact: ZHAO Yanfang, QIN Mingze E-mail:yanfangzhao@126.com;qinmingze001@126.com
Supported by:
Supported by the National Natural Science Foundation of China(No.81502924).

Abstract

Abstract: A novel series of diaryl biuret derivatives containing a tetrazole moiety was designed and synthesized. All the target compounds were evaluated for their in vitro antitumor activity against HT-29, HepG2, MCF-7 and A549 cells by MTT assay. Most of them exhibited obvious antitumor activity, and four of them (4a, 4c, 4h and 7a) were superior to sorafenib in general. Among them, Compound 4h displayed more potent activity than sorafenib in all tested cancer cells. Compound 4c exhibited the most outstanding activity in inhibition of growth of HepG2 cells (IC₅₀=0.55 μmol/L). Further, they both revealed favorable metabolic stability in in vitro assay. Compounds 4c and 4h are promising candidates for further development.

Key words: Sorafenib derivative, Tetrazole moiety, Antitumor activity

TIAN Ye, YU Simiao, CAI Lude, GONG Guowei, WU Guodong, QI Hongxia, ZHAO Yanfang, QIN Mingze. Synthesis and Antitumor Activity of Sorafenib Analogs Containing a Tetrazole Moiety[J]. Chemical Research in Chinese Universities, 2019, 35(1): 41-46.

References

[1] Gild M. L., Bullock M., Robinson B. G., Cliftonbligh R., Nat. Rev. Endocrinol., 2011, 7(7), 617
[2] Nagilla M., Brown R. L., Cohen E. E. W., Adv. Ther., 2012, 29(11), 925
[3] Kataoka Y., Mukohara T., Tomioka H., Funakoshi Y., Kiyota N., Fujiwara Y., Yashiro M., Hirakawa K., Hirai M., Minami H., Invest. New Drug., 2012, 30, 1352
[4] Okamoto K., Ikemorikawada M., Jestel A., Konig K., Funahashi Y., Matsushima T., Tsuruoka A., Inoue A., Matsui J., Acs Med. Chem. Lett., 2015, 6(1), 89
[5] Bai X., Ma X., Xie X., Shao M., Guo N., Yan N., Yao L., Chem. J. Chinese Universities., 2017, 38(1), 47
[6] Ma R., Chen J., Liang Y., Linb S., Zhub L., Liangb X., Caib X., Biomed. Pharmacother., 2017, 88, 459
[7] Wilhelm S., Adnane L., Newell P., Villanueva A., Llovet J., Lynch M., Mol. Cancer Ther., 2008, 7, 3129
[8] Copur M. S., Obermiller A., Clin. Colorectal Canc., 2011, 10(3), 151
[9] Mattina J., Mackinnon N., Henderson V. C., Fergusson D., Kimmelman J., Cancer Res., 2016, 76(16), 4627
[10] Liu C., Chen Z., Chen Y., Lu J., Li Y., Wang S., Wu G., Qian F., Mol. Pharm., 2016, 13, 599
[11] Jiang S., Qin Y., Wu S., Xu S., Li K., Yang P., Zhao K., Lin L., Gong J., J. Chem. Eng. Data, 2017, 62, 259
[12] Temirak A., Abdulla M., Elhefnawi M., Anticancer Agents Med. Chem., 2012, 12, 1088
[13] Liao J. J., J. Med. Chem., 2007, 38(22), 409
[14] Lin X., Huang X. P., Chen G., Whaley R., Peng S., Wang Y., Zhang G., Wang S. X., Wang S., Roth B. L., Huang N., J. Med. Chem., 2012, 55(12), 5749
[15] Wang Y., Qin M., Hu G., Wang T., Nie M., Wu D., Gong P., Chinese Journal of Medicinal Chemistry, 2014, 24(5), 345
[16] Qin M., Liao W., Xu C., Fu B., Ren J., Gu Y., Gong P., Arch. Pharm., 2013, 346(11), 840
[17] Khan A. A., Siddiqui N., Akhtar M. J., Ali Z., Yar M. S., Arch. Pharm., 2016, 349(4), 277
[18] Pireddu R., Forinash K. D., Sun N. N., Martin M. P., Sung S. S., Alexander B., Zhu J. Y., Guida W. C., Schonbrunn E., Sebti S. M., Lawrence N. J., Medchemcomm., 2012, 3(6), 699
[19] Fouladdel S., Khalaj A., Adibpour N., Azizi E., Bioorg. Med. Chem. Lett., 2010, 20(19), 5772
[20] Cai W., Liu W., Xie Y., Wu J., Liu Y., Liu C., Xu W., Tang L., Wang J., Zhao G., Chem. Res. Chinese Universities, 2017, 33(1), 1
[21] Yao P., Zhai X., Liu D., Qi B. H., Tan H. L., Jin Y. C., Gong P., Arch. Pharm., 2010, 343(1), 17
[22] Wu H., Handoko, Raj M., Arora P. S., Org. Lett., 2017, 19(19), 5122

Synthesis and Antitumor Activity of Sorafenib Analogs Containing a Tetrazole Moiety

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHANG Xiulan, ZHANG Huan, MA Jinlong, YU Shujing, LI Zhengming. Design, Synthesis and Biological Activities of Novel N-Aryl-1H-pyrazole-5-carboxylate Derivatives [J]. Chemical Research in Chinese Universities, 2020, 36(5): 853-858.
[2]	ZHANG Xiulan, ZHANG Huan, LIU Jingbo, XIONG Lixia, LI Zhengming. Synthesis and Biological Evaluation of Novel Anthranilic Diamides Containing N-H/CH₃-1H-Pyrazole [J]. Chemical Research in Chinese Universities, 2020, 36(5): 829-834.
[3]	LI Hongshuang, WANG Xinran, DUAN Guiyun, XIA Chengcai, XIAO Yuliang, LI Furong, GE Yanqing, YOU Guirong, HAN Junfen, FU Xiaopan, TAN Shanhui, WANG Rongwei. Synthesis, Antitumor Activity and Preliminary Structure-activity Relationship of 2-Aminothiazole Derivatives [J]. Chemical Research in Chinese Universities, 2016, 32(6): 929-937.
[4]	MA Junjie, HU Gang, XIE Lijun, CHEN Lei, XU Boxuan, GONG Ping. Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives Bearing Semicarbazone Moiety as Antitumor Agents [J]. Chemical Research in Chinese Universities, 2015, 31(6): 958-963.
[5]	SUN Bing, YIN Xiu'e, ZHANG Jin, HUANG Jian, XU Yue, ZHANG Furong, WANG Jinhui, WANG Guoqing, HU Chun. Synthesis, Characterization and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives asEpidermal Growth Factor Receptor Inhibitors [J]. Chemical Research in Chinese Universities, 2015, 31(6): 936-941.
[6]	SHEN Lihong, HU Junping, WANG Haixian, WANG Aibing, LAI Yisheng, KANG Yanhui. Synthesis and Biological Evaluation of Novel Uracil and 5-Fluorouracil-1-yl Acetic Acid-Colchicine Conjugate [J]. Chemical Research in Chinese Universities, 2015, 31(3): 367-371.
[7]	JIA Xuedong, LIU Xiujun, WANG Jian, WANG Minghua, GUO Huiyuan, LIU Mingliang. Synthesis and Antitumor Activity of Capecitabine Derivatives [J]. Chemical Research in Chinese Universities, 2015, 31(1): 78-83.
[8]	LIAO Huimin, CHONG Lian'e, TAN Li, CHEN Xiaodan, YOU Rui, GONG Ping. Synthesis and Biological Evaluation of Novel 5,7-Diphenylimidazo[1,2-a]pyridine Derivatives [J]. Chemical Research in Chinese Universities, 2014, 30(5): 759-763.
[9]	ZHAO Jie, XUAN Lina, ZHAO Haichuan, CHENG Ji, FU Xiaoyun, LI Sha, JING Fen, LIU Yuming, CHEN Baoquan. Synthesis and Antitumor Activities of 1,3,4-Thiadiazole Derivatives Possessing Benzisoselenazolone Scaffold [J]. Chemical Research in Chinese Universities, 2014, 30(5): 764-769.
[10]	YE Jiao, QIU Shenyi, HU Aixi, PENG Junmei, QIN Zhi. Synthesis and Antitumor Activity of 4-tert-Butyl-5-benzyl-2-benzyliminothiazoles [J]. Chemical Research in Chinese Universities, 2014, 30(1): 49-54.
[11]	SONG Kaizhen, MA Junjie, WANG Xiao, GONG Ping, ZHAO Yanfang. Synthesis and Antitumor Activities of Novel 4-Morpholinothieno[3,2-d]pyrimidine Derivatives [J]. Chemical Research in Chinese Universities, 2014, 30(1): 75-81.
[12]	LIU Zhi-hui, LI De-jun, JIANG Dan, XIAO Chuan, SONG Zhi-guang, JIN Ying-hua. Design, Synthesis and Antitumor Activity in vitro of a Series of 3-Arylcoumarins [J]. Chemical Research in Chinese Universities, 2013, 29(6): 1125-1128.
[13]	ZHANG Xiu-lan, LIU Ai-lin, ZHAO Yu, XIONG Li-xia, LI Zheng-ming. Synthesis and Biological Activity of Novel Anthranilic Diamides Containing N-Substituted Arylmethylene Moieties [J]. Chemical Research in Chinese Universities, 2013, 29(6): 1134-1139.
[14]	ZHANG Hao, ZHENG Yu-qiong, GUO Jing, WANG Xiao-ming, YANG Yong-hua. Synthesis, Docking and Biological Evaluation of Isoquinolonic Acid Derivatives [J]. Chemical Research in Chinese Universities, 2013, 29(6): 1110-1114.
[15]	LOU Xi-yu, YANG Xuan, DING Yi-li, WANG Jian-jun, YAN Qing-yan, HUANG Xian-gui, GUO Yang-hui, WANG Xiang-jing, XIANG Wen-sheng. Synthesis of Olaparib Derivatives and Their Antitumor Activities [J]. Chemical Research in Chinese Universities, 2013, 29(2): 231-235.